CLINICAL_TRIALS
trial_result
· 2017-02-07
Clinical Trial Update: Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women [Phase 3]
Summary
Phase 3 trial update for a quadrivalent HPV vaccine aiming to prevent anal HPV infection in HIV-infected individuals; results completed with posted results in 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-02-07